<![CDATA[셀트리온헬스케어 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=36825>Sat, 18 Apr 2026 09:00:15 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Celltrion announces positive results for its cocktail therapy candidates including neutralisation data against Omicron variant]]>https://www.newswire.co.kr/newsRead.php?no=937560Tue, 04 Jan 2022 09:55:56 +0900<![CDATA[Celltrion’s COVID-19 Treatment Candidate Receives Korean MFDS Conditional Marketing Authorisation]]>https://www.newswire.co.kr/newsRead.php?no=918321Mon, 08 Feb 2021 09:54:59 +0900<![CDATA[Celltrion Group announces positive top-line efficacy and safety data from global Phase II/III clinical trial of COVID-19 treatment candidate CT-P59]]>https://www.newswire.co.kr/newsRead.php?no=917256Thu, 14 Jan 2021 11:08:06 +0900